tiprankstipranks
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market
Holding VRNA?
Track your performance easily

Verona Pharma (VRNA) Technical Analysis

692 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 3.34, suggesting Verona Pharma Plc is a Sell.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 51.77, while Verona Pharma Plc’s (VRNA) share price is $57.3, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 46.29, while Verona Pharma Plc’s (VRNA) share price is $57.3, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Feb 01, 2025, 05:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
51.32
52.97
55.11
56.76
58.90
60.55
62.69
Fibonacci
52.97
54.42
55.32
56.76
58.21
59.11
60.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Feb 01, 2025, 05:37 PM
Period
Simple
Exponential
MA5
55.26Buy
55.81Buy
MA10
54.54Buy
54.35Buy
MA20
51.25Buy
51.77Buy
MA50
45.11Buy
46.29Buy
MA100
38.94Buy
40.20Buy
MA200
28.72Buy
31.14Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 54.35, while Verona Pharma Plc’s (VRNA) share price is $57.3, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 40.20, while Verona Pharma Plc’s (VRNA) share price is $57.3, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $57.3 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 45.11, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $57.3 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 38.94, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $57.3 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 28.72, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Feb 01, 2025, 05:37 PM
Name
Value
Implied Action
RSI (14)
69.36
Neutral
STOCH (9,6)
84.19
Sell
STOCHRSI (14)
91.77
Sell
MACD (12,26)
3.34
Sell
ADX (14)
52.81
Sell
Williams %R
-8.15
Sell
CCI (14)
118.84
Sell
ATR (14)
2.71
-
Ultimate Oscillator
56.46
Neutral
ROC
26.77
Buy
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 69.36, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 52.81, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 118.84, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is 26.77, creating a Buy signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 69.36, which suggests VRNA is a Neutral.
      What is VRNA’s MACD?
      VRNA’s MACD is 3.34, which suggests VRNA is a Sell.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 55.26, which suggests VRNA is a Buy.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 51.25, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 45.11, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 28.72, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -8.15, which suggests VRNA is a Sell.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 118.84, which suggests VRNA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis